1. Home
  2. ZUMZ vs ALLO Comparison

ZUMZ vs ALLO Comparison

Compare ZUMZ & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZUMZ
  • ALLO
  • Stock Information
  • Founded
  • ZUMZ 1978
  • ALLO 2017
  • Country
  • ZUMZ United States
  • ALLO United States
  • Employees
  • ZUMZ N/A
  • ALLO N/A
  • Industry
  • ZUMZ Clothing/Shoe/Accessory Stores
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ZUMZ Consumer Discretionary
  • ALLO Health Care
  • Exchange
  • ZUMZ Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • ZUMZ 401.1M
  • ALLO 431.9M
  • IPO Year
  • ZUMZ 2005
  • ALLO 2018
  • Fundamental
  • Price
  • ZUMZ $20.42
  • ALLO $2.07
  • Analyst Decision
  • ZUMZ Hold
  • ALLO Buy
  • Analyst Count
  • ZUMZ 2
  • ALLO 12
  • Target Price
  • ZUMZ $22.00
  • ALLO $10.06
  • AVG Volume (30 Days)
  • ZUMZ 306.3K
  • ALLO 2.5M
  • Earning Date
  • ZUMZ 12-05-2024
  • ALLO 11-07-2024
  • Dividend Yield
  • ZUMZ N/A
  • ALLO N/A
  • EPS Growth
  • ZUMZ N/A
  • ALLO N/A
  • EPS
  • ZUMZ N/A
  • ALLO N/A
  • Revenue
  • ZUMZ $891,864,000.00
  • ALLO $43,000.00
  • Revenue This Year
  • ZUMZ $4.32
  • ALLO N/A
  • Revenue Next Year
  • ZUMZ $2.19
  • ALLO N/A
  • P/E Ratio
  • ZUMZ N/A
  • ALLO N/A
  • Revenue Growth
  • ZUMZ 2.07
  • ALLO 26.47
  • 52 Week Low
  • ZUMZ $12.90
  • ALLO $1.83
  • 52 Week High
  • ZUMZ $31.37
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • ZUMZ 43.75
  • ALLO 41.06
  • Support Level
  • ZUMZ $19.47
  • ALLO $1.83
  • Resistance Level
  • ZUMZ $22.22
  • ALLO $2.09
  • Average True Range (ATR)
  • ZUMZ 1.35
  • ALLO 0.14
  • MACD
  • ZUMZ -0.24
  • ALLO -0.01
  • Stochastic Oscillator
  • ZUMZ 23.63
  • ALLO 30.38

About ZUMZ Zumiez Inc.

Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: